Related Experiment Video
Updated: May 13, 2026
04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers
Neuroscience
|March 20, 2013
Summary
Leptin and ghrelin protect brain cells from Alzheimer's disease (AD) toxins. These hormones reduce damage and cell death in the hippocampus, suggesting a potential therapeutic role for AD.
Area of Science:
- Neuroscience
- Endocrinology
- Cell Biology
Background:
- Ghrelin and leptin influence learning and memory via the hippocampus.
- Altered levels of these peptides are observed in Alzheimer's disease (AD) patients, correlating with cognitive decline.
- Previous studies suggest leptin and ghrelin may mitigate AD pathologies and cognitive deficits.
Purpose of the Study:
- To investigate the neuroprotective potential of leptin and ghrelin against amyloid-β oligomer (AβO)-induced hippocampal dysfunction in AD.
- To elucidate the mechanisms underlying the protective effects of these peptides.
Main Methods:
- Primary cultured hippocampal neurons were used to assess the effects of leptin and ghrelin on AβO toxicity.
- Measurements included superoxide production, mitochondrial membrane potential, cell survival, and glycogen synthase kinase 3β (GSK-3β) activation.
Main Results:
- Leptin and ghrelin reduced AβO-induced superoxide production and mitochondrial depolarization.
- Both peptides improved neuronal survival and inhibited cell death via a receptor-dependent mechanism.
- Leptin and ghrelin prevented GSK-3β activation in AβO-treated neurons.
Conclusions:
- Leptin and ghrelin demonstrate neuroprotective effects against AβO toxicity in hippocampal neurons.
- These findings highlight the potential therapeutic utility of leptin and ghrelin for Alzheimer's disease.
